SCHEMBL15902145

SCHEMBL15902145

O=Cc1cccc2c(Br)c3cccc(C=O)c3cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
LMNA P02545 2/20 0.44
THRB P10828 1/20 0.44
BLM P54132 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
TRIM24 O15164 3/20 0.41
TRIM33 Q9UPN9 3/20 0.41
ERN1 O75460 3/20 0.39
ALDH1A1 P00352 2/20 0.39
TSHR P16473 1/20 0.37
PIM1 P11309 1/20 0.37
PIM3 Q86V86 1/20 0.37
KDM4E B2RXH2 2/20 0.36
PABPC1 P11940 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP2A6 P11509 6/20 0.35
IMPDH2 P12268 1/20 0.35
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10488322 0.87 MEN1 (0.41) MEN1KMT2ALMNATHRBBLM
SCHEMBL9797604 0.81 KMT2A (0.42) MEN1KMT2ALMNATHRBBLM
SCHEMBL4245330 0.78 MEN1 (0.61) MEN1KMT2ALMNATHRBBLM
SCHEMBL1232196 0.76 LMNA (0.58) MEN1KMT2ALMNATHRBBLM
SCHEMBL17422062 0.76 LMNA (0.52) MEN1KMT2ALMNATHRBBLM
SCHEMBL1394290 0.76 MEN1 (0.46) MEN1KMT2ALMNATHRBBLM
SCHEMBL27768942 0.75 MEN1 (0.47) MEN1KMT2ALMNATHRBBLM
SCHEMBL1817898 0.73 MEN1 (0.48) MEN1KMT2ALMNATHRBBLM
SCHEMBL31661013 0.71 CYP2A6 (0.49) MEN1KMT2ALMNATHRBBLM
SCHEMBL31620481 0.71 PIM1 (0.45) MEN1KMT2ALMNATHRBBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140212575-A1 Novel Self-Assembling Nanocomposite Structures and Methods of Preparing Same THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE 2014-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140212575-A1 Novel Self-Assembling Nanocomposite Structures and Methods of Preparing Same CACYBP, CAPG, NCBP2 MEN1 2018/4885KMT2A 2515/4885LMNA 1942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.